Evidence map›Paper›PMID 30955487›Full record

ReviewPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2019

Infection and immune control of human oncogenic γ-herpesviruses in humanized mice.

Donal McHugh, Nicole Caduff, Anita Murer, Christine Engelmann, Yun Deng, Hana Zdimerova, Kyra Zens, Obinna Chijioke, Christian Münz

Abstract readReview
In one paragraph

Review in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. LANA-specific CD4Nature communications · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Vaccination against the Epstein-Barr virus.Cellular and molecular life sciences : CMLS · 2020
    Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Donal McHughViral Immunobiology, Institute of Experimental Immunology, University of Zürich , Switzerland.
Nicole CaduffViral Immunobiology, Institute of Experimental Immunology, University of Zürich , Switzerland.
Anita MurerViral Immunobiology, Institute of Experimental Immunology, University of Zürich , Switzerland.
Christine EngelmannViral Immunobiology, Institute of Experimental Immunology, University of Zürich , Switzerland.
Yun DengViral Immunobiology, Institute of Experimental Immunology, University of Zürich , Switzerland.
Hana ZdimerovaViral Immunobiology, Institute of Experimental Immunology, University of Zürich , Switzerland.
Kyra ZensViral Immunobiology, Institute of Experimental Immunology, University of Zürich , Switzerland.
Obinna ChijiokeViral Immunobiology, Institute of Experimental Immunology, University of Zürich , Switzerland.
Christian MünzViral Immunobiology, Institute of Experimental Immunology, University of Zürich , Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epstein-Barr virus (EBV) and Kaposi sarcoma-associated herpesvirus (KSHV) comprise the oncogenic human γ-herpesvirus family and are responsible for 2-3% of all tumours in man. With their prominent growth-transforming abilities and high prevalence in the human population, these pathogens have probably shaped the human immune system throughout evolution for near perfect immune control of the respective chronic infections in the vast majority of healthy pathogen carriers. The exclusive tropism of EBV and KSHV for humans has, however, made it difficult in the past to study their infection, tumourigenesis and immune control in vivo. Mice with reconstituted human immune system components (humanized mice) support replication of both viruses with both persisting latent and productive lytic infection. Moreover, B-cell lymphomas can be induced by EBV alone and KSHV co-infection with gene expression hallmarks of human malignancies that are associated with both viruses. Furthermore, cell-mediated immune control by primarily cytotoxic lymphocytes is induced upon infection and can be probed for its functional characteristics as well as putative requirements for its priming. Insights that have been gained from this model and remaining questions will be discussed in this review. This article is part of the theme issue 'Silent cancer agents: multi-disciplinary modelling of human DNA oncoviruses'.

Indexed as

AnimalsDisease Models, AnimalEpstein-Barr Virus InfectionsHerpesvirus 4, HumanHerpesvirus 8, HumanHumansMiceMice, TransgenicSarcoma, Kaposianti-viral immune controlEpstein–Barr virushumanized miceKaposi sarcoma-associated herpesviruslymphoma

Identifiers

PMID30955487
PMCPMC6501906

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.